
Our platforms are catalyzing drug discoveryfor all major diseases
ELVIS™&ROSALYND™
We are therapeutic area agnostic, and are currently applying our platforms to novel hit discovery, hit-to-lead, and lead optimization campaigns in the following disease areas.
Neuroscience
Chronic pain

Infectious Disease
covid-19, non-tuberculosis mycobacterium (NTM)

Immunology
Psoriasis, Multiple Sclerosis

Oncology
Blood Cancers, Solid tumors

Aging
eye disorders, Osteoarthritis

Metabolism
Type I & Type II Diabetes, Hypercholesterolemia
